Aster Capital Management’s Jade Biosciences JBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding JBIO
Aster Capital Management's JBIO Position: Q3 2026 in Review
Aster Capital Management reduced its Jade Biosciences (JBIO) stake by 72% in Q3 2026, selling an estimated $17K and leaving 328 shares worth $4.61K. The position accounts for ﹤0.01% of the portfolio, ranked #856.
Aster Capital Management first reported a position in JBIO in Q4 2025 and has held it in 3 quarters since. The position peaked at $26.1K in Q2 2026. 162 funds tracked by Wall St. Rank hold JBIO as of Q3 2026.
- Aster Capital Management held 328 shares of Jade Biosciences worth $4.61K as of Q3 2026.
- Aster Capital Management sold 848 Jade Biosciences shares in Q3 2026, an estimated $17K.
- Jade Biosciences made up ﹤0.01% of Aster Capital Management's portfolio in Q3 2026, its #856 holding.
- Aster Capital Management first reported a position in Jade Biosciences in Q4 2025 and has held it in 3 quarters since.
- Aster Capital Management's Jade Biosciences position peaked at $26.1K in Q2 2026.
- 162 funds tracked by Wall St. Rank held Jade Biosciences as of Q3 2026.
Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.